Numans Health Food Holdings Co (HKSE:02530) Research & Development: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02530 Numans Health Food Holdings Co Ltd HKSE:02530
23 GF Score
Price HK$0.76
! 7 Warning Signs
View Full Analysis

What is Numans Health Food Holdings Co Research & Development?

Numans Health Food Holdings Co HKSE:02530 +1.34% 23 Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02530 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Numans Health Food Holdings Co's Research & Development for the six months ended in Dec. 2025 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Numans Health Food Holdings Co  (HKSE:02530) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Numans Health Food Holdings Co Research & Development Related Terms

Numans Health Food Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for Numans Health Food Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numans Health Food Holdings Co Research & Development Chart

Numans Health Food Holdings Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Numans Health Food Holdings Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02530
23GF Score
Numans Health Food Holdings Co Ltd HKSE:02530
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Numans Health Food Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
Numans Health Food Holdings Co (HKSE:02530) has a Research & Development of HK$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Numans Health Food Holdings Co and its competitors.
Is Numans Health Food Holdings Co's Research & Development too high?
Numans Health Food Holdings Co's current Research & Development is HK$0.0 Mil. Overall, Numans Health Food Holdings Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Numans Health Food Holdings Co's Research & Development compare to KHC and GIS?
Numans Health Food Holdings Co's Research & Development of HK$0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Numans Health Food Holdings Co and its competitors. Numans Health Food Holdings Co's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numans Health Food Holdings Co stock overvalued right now?
Numans Health Food Holdings Co (HKSE:02530) has a current Research & Development of HK$0.0 Mil. The current Research & Development is HK$0.0 Mil. Numans Health Food Holdings Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Numans Health Food Holdings Co (HKSE:02530), the current Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numans Health Food Holdings Co Business Description

Address Wuxing Road, Building 8, Lane 706, Pudong New Area, Shanghai, CHN
Numans Health Food Holdings Co Ltd is engaged in the marketing, sales and distribution of finished nutritional products in the PRC. The company sells its nutritional products under proprietary brands, namely Nemans, which can be broadly categorized into five main types, namely algal oil DHA, probiotics, vitamins, multi-nutrients, and algal calcium products.
23GF Score

Get the complete analysis for HKSE:02530

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.76
Price